Contact this trialFirst, we need to learn more about you.
cMET Inhibitor
INC280 for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 2
Los Angeles, California
This trial will evaluate a new drug to treat advanced lung cancer in patients who have a specific gene mutation. The trial will also look at the safety and how the body processes the drug.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.